News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News Don't cut prices, cut taxes, pharma CEO tells Trump Industry plays key role in job creation too, says Novartis CEO.
News NICE recommends Novartis kidney cancer drug Afinitor finally recommended after rejection in 2011.
News Trump pledges 'bidding' to cut drug prices, stocks tumble Donald Trump’s first press conference of the year may have been farcical at times, as he fought off salacious allegations about his links with Russia, but the president-elect's attack on dr
News Trump 'already understands' need to incentivise R&D, says Me... Frazier takes swipe at price-hiking generics firms.
US Vericel hopes for US hit with Maci knee treatment Tissue engineering product previously flopped in EU.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
